Skip to Main Content

Author Details

Takehiro Takahashi
Yale University School of Medicine
2011
98
27
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
33479140Sex differences in immune responses.Science2021
32232898Clinical significance of endothelial vasodilatory function evaluated by EndoPAT in patients with systemic sclerosis.J Dermatol2020
31782787Fli1 deficiency induces endothelial adipsin expression, contributing to the onset of pulmonary arterial hypertension in systemic sclerosis.Rheumatology (Oxford)2020
31959382Regulation of skin fibrosis by RALDH1-producing dermal dendritic cells via retinoic acid-mediated regulatory T cell induction: A role in scleroderma.J Dermatol Sci2020
32577695Sex differences in immune responses to SARS-CoV-2 that underlie disease outcomes.medRxiv2020
32627966Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5<sup>+/-</sup> ;Fli-1<sup>+/-</sup> Mice.Arthritis Rheumatol2020
32846427Sex differences in immune responses that underlie COVID-19 disease outcomes.Nature2020
30520152A potential contribution of trappin-2 to the development of vasculopathy in systemic sclerosis.J Eur Acad Dermatol Venereol2019
30168849Assessment of endothelial function during the loading phase of infliximab in psoriasis: a potential predictor of its drug survival.Int J Dermatol2019
31502326Rituximab therapy is more effective than cyclophosphamide therapy for Japanese patients with anti-topoisomerase I-positive systemic sclerosis-associated interstitial lung disease.J Dermatol2019
30858571Aedes aegypti AgBR1 antibodies modulate early Zika virus infection of mice.Nat Microbiol2019
31079997Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?J Dermatol Sci2019
30270117Increased expression of aquaporin-1 in dermal fibroblasts and dermal microvascular endothelial cells possibly contributes to skin fibrosis and edema in patients with systemic sclerosis.J Dermatol Sci2019
28681537A potential contribution of psoriasin to vascular and epithelial abnormalities and inflammation in systemic sclerosis.J Eur Acad Dermatol Venereol2018
29947047CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis.Exp Dermatol2018
30268392Progranulin overproduction due to constitutively activated c-Abl/PKC-δ/Fli1 pathway contributes to the resistance of dermal fibroblasts to the anti-fibrotic effect of tumor necrosis factor-α in localized scleroderma.J Dermatol Sci2018
30289572Prediction of therapeutic response before and during i.v. cyclophosphamide pulse therapy for interstitial lung disease in systemic sclerosis: A longitudinal observational study.J Dermatol2018
29415756Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells.Arthritis Res Ther2018
29279288Systemic sclerosis complicated with localized scleroderma-like lesions induced by Köbner phenomenon.J Dermatol Sci2018
29044628Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis.J Dermatol2018
29265579Successful treatment with rituximab in a Japanese patient with systemic sclerosis-associated interstitial lung disease resistant to oral steroid and cyclophosphamide.J Dermatol2018
27538472Plasma plasmin-α2-plasmin inhibitor complex levels may predict the effect of cyclophosphamide for systemic sclerosis-related interstitial lung disease.Mod Rheumatol2017
28389593CXCL17 Attenuates Imiquimod-Induced Psoriasis-like Skin Inflammation by Recruiting Myeloid-Derived Suppressor Cells and Regulatory T Cells.J Immunol2017
28232470Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: Possible roles in scleroderma.J Exp Med2017
28432700Serum H-ficolin levels: Clinical association with interstitial lung disease in patients with systemic sclerosis.J Dermatol2017
28497874Serum angiopoietin-2 level as a potential biomarker in psoriasis vulgaris.J Dermatol2017
28378437Serum LL-37 levels correlate with the efficacy of i.v. cyclophosphamide pulse for skin sclerosis and interstitial lung disease in systemic sclerosis.J Dermatol2017
28370536The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis.Exp Dermatol2017
29038846A possible implication of reduced levels of LIF, LIFR, and gp130 in vasculopathy related to systemic sclerosis.Arch Dermatol Res2017
28507181Fli1 Deficiency Induces CXCL6 Expression in Dermal Fibroblasts and Endothelial Cells, Contributing to the Development of Fibrosis and Vasculopathy in Systemic Sclerosis.J Rheumatol2017
28528914Systemic Sclerosis Dermal Fibroblasts Suppress Th1 Cytokine Production via Galectin-9 Overproduction due to Fli1 Deficiency.J Invest Dermatol2017
27900875Unprecedented success of rituximab therapy for prednisolone- and immunosuppressant-resistant systemic sclerosis-associated interstitial lung disease.Scand J Rheumatol2017
27777101Glycyrrhizin Ameliorates Fibrosis, Vasculopathy, and Inflammation in Animal Models of Systemic Sclerosis.J Invest Dermatol2017
28026802Ethosuximide-induced lupus-scleroderma syndrome with disease-specific autoantibodies.Eur J Dermatol2017
24499427A case of scleredema adultorum successfully treated with narrow-band ultraviolet B phototherapy.Mod Rheumatol2016
26661692A potential contribution of altered cathepsin L expression to the development of dermal fibrosis and vasculopathy in systemic sclerosis.Exp Dermatol2016
26567180Nucleosome in patients with systemic sclerosis: possible association with immunological abnormalities via abnormal activation of T and B cells.Ann Rheum Dis2016
26399195Fli1 deficiency contributes to the downregulation of endothelial protein C receptor in systemic sclerosis: a possible role in prothrombotic conditions.Br J Dermatol2016
27129435Linear scleroderma with prominent multiple lymphadenopathy followed by the development of polymyositis: A case report and review of published work.J Dermatol2016
26967475Tamibarotene Ameliorates Bleomycin-Induced Dermal Fibrosis by Modulating Phenotypes of Fibroblasts, Endothelial Cells, and Immune Cells.J Invest Dermatol2016
26777734Serum levels of interleukin-18-binding protein isoform a: Clinical association with inflammation and pulmonary hypertension in systemic sclerosis.J Dermatol2016
27086491The development of chronic inflammatory demyelinating polyneuropathy during adalimumab treatment in a patient with psoriasis vulgaris.Eur J Dermatol2016
26825047Decreased interleukin-21 expression in skin and blood in advanced mycosis fungoides.J Dermatol2016
26876001Association of anti-RNA polymerase III antibody and silicone breast implants in patients with systemic sclerosis.J Dermatol2016
27105895A potential contribution of antimicrobial peptide LL-37 to tissue fibrosis and vasculopathy in systemic sclerosis.Br J Dermatol2016
26727543The first case report of fatal acute pulmonary dysfunction in a systemic sclerosis patient treated with rituximab.Scand J Rheumatol2016
26173737Scleroderma en coup de sabre with recurrent episodes of brain hemorrhage.J Dermatol2016
25976154Serum IL-33 levels are increased in patients with psoriasis.Clin Exp Dermatol2016
24517166Circulating galectin-1 concentrations in systemic sclerosis: potential contribution to digital vasculopathy.Int J Rheum Dis2016
24593173Effect of ambrisentan on peripheral circulation in patients with systemic sclerosis.Mod Rheumatol2016
  • 1 - 50 of 98

Recommended Authors

University of California san francisco
Career Start Year 2014
Number of shared co-authors 0
Institute of Medicine, University of Tsukuba
Career Start Year 2011
Number of shared co-authors 13
Herlev and Gentofte Hospital, University of Copenhagen
Career Start Year 2011
Number of shared co-authors 0
Mount Sinai Hospital.
Career Start Year 2011
Number of shared co-authors 0
Geisel School of Medicine at Dartmouth
Career Start Year 2010
Number of shared co-authors 0
Departamento de Genetica e Instituto de Biotecnologia, Universidad de Granada
Career Start Year 2010
Number of shared co-authors 0
Schroeder Arthritis Institute, Krembil Research Institute, University Health Network
Career Start Year 2009
Number of shared co-authors 0
Geisel School of Medicine at Dartmouth
Career Start Year 2008
Number of shared co-authors 0
Medical Subspecialities Institute, Cleveland Clinic
Career Start Year 2008
Number of shared co-authors 0
Yale School of Medicine
Career Start Year 2007
Number of shared co-authors 2
Cellular Biomedicine Group Inc.
Career Start Year 2005
Number of shared co-authors 0
Toronto Western Hospital, University of Toronto
Career Start Year 2003
Number of shared co-authors 0
Beth Israel Deaconess Hospital
Career Start Year 2003
Number of shared co-authors 0
Scleroderma Clinic, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
Career Start Year 2001
Number of shared co-authors 0
National Institute of Arthritis and Musculoskeletal and Skin Diseases
Career Start Year 1999
Number of shared co-authors 0
Tokyo Medical and Dental University
Career Start Year 1998
Number of shared co-authors 0
Peking Union Medical College Hospital (PUMCH)
Career Start Year 1998
Number of shared co-authors 0
Novartis Pharma AG
Career Start Year 1995
Number of shared co-authors 0
Geisel School of Medicine at Dartmouth
Career Start Year 1995
Number of shared co-authors 0
Corbus Pharmaceuticals Holdings
Career Start Year 1994
Number of shared co-authors 0
Kaohsiung Veterans General Hospital
Career Start Year 1992
Number of shared co-authors 0
West Virginia University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
Centre Hospitalo-Universitaire de Rouen
Career Start Year 1988
Number of shared co-authors 0
Johns Hopkins University
Career Start Year 1988
Number of shared co-authors 0
University of Occupational and Environmental Health
Career Start Year 1986
Number of shared co-authors 0
Albert Einstein College of Medicine
Career Start Year 1986
Number of shared co-authors 0
University of Texas McGovern Medical School
Career Start Year 1985
Number of shared co-authors 0
University of Texas
Career Start Year 1983
Number of shared co-authors 0
University of Toronto
Career Start Year 1976
Number of shared co-authors 0
Schroeder Arthritis Institute, Krembil Research Institute, Toronto Western Hospital
Career Start Year 1975
Number of shared co-authors 0

Collaborators

Yale University
Co-authored papers 4
Co-authored papers 4
Yale School of Public Health
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers 2
School of Public Health, Yale University
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Christian Medical College
Co-authored papers 2
Yale University School of Public Health, 60 College St
Co-authored papers 2
Yale School of Public Health
Co-authored papers 2
Yale School of Public Health
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
Yale School of Public Health
Co-authored papers 2
Boyer Center for Molecular Medicine, Yale University
Co-authored papers 2
Department of Microbial Pathogenesis Yale University New Haven
Co-authored papers 2
Yale School of Public Health
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 2
Yale School of Public Health
Co-authored papers 2
Yale School of Medicine
Co-authored papers 2
College of Science & Industry Convergence, Ewha Womans University
Co-authored papers 2
Yale University School of Medicine
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
Yale School of Medicine, Yale School of Public Health
Co-authored papers 1
Yale School of Public Health
Co-authored papers 1
Yale University
Co-authored papers 1
Yale School of Medicine, Yale University
Co-authored papers 1